Hyperparathyroidism: Time to reconsider current clinical decision paradigms?

Abstract

[No abstract available]Albright F., 1948, PARATHYROID GLANDS M; Ambrogini E, 2007, J CLIN ENDOCR METAB, V92, P3114, DOI 10.1210-jc.2007-0219; Bilezikian JP, 2002, J CLIN ENDOCR METAB, V87, P353; Bilezikian JP, 2004, NEW ENGL J MED, V350, P1746, DOI 10.1056-NEJMcp032200; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210-jc.2006-1836; Eriksen EF, 2002, J BONE MINER RES, V17, pN95; Guo CY, 1996, J CLIN ENDOCR METAB, V81, P3487, DOI 10.1210-jc.81.10.3487; Khosla S, 2002, J BONE MINER RES, V17, pN103; LARSSON K, 1993, J INTERN MED, V234, P585; Nakchbandi IA, 2008, J CLIN ENDOCR METAB, V93, P967, DOI 10.1210-jc.2007-1645; Nilsson IL, 2002, J BONE MINER RES, V17, pN68; Potts Jr JT, 1991, J BONE MINER RES S2, V6, pS1; RAO DS, 1988, J CLIN ENDOCR METAB, V67, P1294; Roschger P, 2007, J BONE MINER RES, V22, P717, DOI 10.1359-JBMR.070120; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210-jc.2007-1215; SCHOLZ DA, 1981, MAYO CLIN PROC, V56, P473; Siilin H, 2008, J CLIN ENDOCR METAB, V93, P47, DOI 10.1210-jc.2007-0600; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056-NEJM199910213411701; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P4007, DOI 10.1210-jc.81.11.4007; Utiger RD, 1999, NEW ENGL J MED, V341, P1301, DOI 10.1056-NEJM199910213411709; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359-JBMR.050910; 2008, INT WORKSH PRIM HYP52